Relationship between OSA and hypertension

Chest

Volumn 148, Issue 3, 2015, Pages 824-832

  Torres, Gerard ^a   Sánchez De La Torre, Manuel ^a,b   Barbé, Ferran ^a  

^a HOSPITAL UNIVERSITARI ARNAU DE VILANOVA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CILAZAPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; HYDROCHLOROTHIAZIDE; LOSARTAN; METOPROLOL; NEBIVOLOL; SPIRONOLACTONE; VALSARTAN;

AGE; BLOOD PRESSURE; CARDIOVASCULAR RISK; CIRCADIAN RHYTHM; DISEASE ASSOCIATION; DRUG RESPONSE; HUMAN; HYPERALDOSTERONISM; HYPERTENSION; INCIDENCE; OBESITY; ORTHODONTIC DEVICE; PATIENT COMPLIANCE; POSITIVE END EXPIRATORY PRESSURE; PREVALENCE; PRIORITY JOURNAL; RESISTANT HYPERTENSION; REVIEW; SEX; SIDE EFFECT; SLEEP DISORDERED BREATHING; SOMNOLENCE; THERAPY EFFECT; UNSPECIFIED SIDE EFFECT; UPPER RESPIRATORY TRACT OBSTRUCTION; WEIGHT GAIN; WEIGHT REDUCTION; COMPLICATION; PATHOPHYSIOLOGY; RISK FACTOR; SEX DIFFERENCE; SLEEP APNEA, OBSTRUCTIVE;

AGE FACTORS; ANTIHYPERTENSIVE AGENTS; CIRCADIAN RHYTHM; HUMANS; HYPERTENSION; RISK FACTORS; SEX FACTORS; SLEEP APNEA, OBSTRUCTIVE;

EID: 84941637610     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.15-0136     Document Type: Article

References (75)

1. Sánchez-de-la-Torre M, Campos-Rodriguez F, Barbé F. Obstructive sleep apnoea and cardiovascular disease. Lancet Respir Med. 2013; 1 ( 1): 61-72.
2. Durán J, Esnaola S, Rubio R, Iztueta A. Obstructive sleep apneahypopnea and related clinical features in a population-based sample of subjects aged 30 to 70 yr. Am J Respir Crit Care Med. 2001; 163 ( 3 pt 1): 685-689.
3. Peppard PE, Young T, Barnet JH, Palta M, Hagen EW, Hla KM. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol. 2013; 177 ( 9): 1006-1014.
4. Silverberg DS, Oksenberg A. Are sleep-related breathing disorders important contributing factors to the production of essential hypertension? Curr Hypertens Rep. 2001; 3 ( 3): 209-215.
5. Logan AG, Perlikowski SM, Mente A, et al. High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J Hypertens. 2001; 19 ( 12): 2271-2277.
6. Young T, Peppard P, Palta M, et al. Population-based study of sleep-disordered breathing as a risk factor for hypertension. Arch Intern Med. 1997; 157 ( 15): 1746-1752.
7. Nieto FJ, Young TB, Lind BK, et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA. 2000; 283 ( 14): 1829-1836.
8. Lavie P, Herer P, Hoff stein V. Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study. BMJ. 2000; 320( 7233): 479-482.
9. Jhamb M, Unruh M. Bidirectional relationship of hypertension with obstructive sleep apnea. Curr Opin Pulm Med. 2014; 20 ( 6): 558-564.
10. Friedman O, Bradley TD, Chan CT, Parkes R, Logan AG. Relationship between overnight rostral fl uid shift and obstructive sleep apnea in drug-resistant hypertension. Hypertension. 2010; 56 ( 6): 1077-1082.
11. Wolk R, Somers VK. Obesity-related cardiovascular disease: implications of obstructive sleep apnea. Diabetes Obes Metab. 2006; 8 ( 3): 250-260.
12. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med. 2000; 342 ( 19): 1378-1384.
13. Chobanian AV, Bakris GL, Black HR, et al; Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee; National Hight Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of high blood pressure. Hypertension. 2003; 42 ( 6): 1206-1252.
14. Marin JM, Agusti A, Villar I, et al. Association between treated and untreated obstructive sleep apnea and risk of hypertension. JAMA. 2012; 307 ( 20): 2169-2176.
15. Bixler EO, Vgontzas AN, Lin HM, et al. Association of hypertension and sleep-disordered breathing. Arch Intern Med. 2000; 160 ( 15): 2289-2295.
16. Haas DC, Foster GL, Nieto FJ, et al. Age-dependent associations between sleep-disordered breathing and hypertension: importance of discriminating between systolic/diastolic hypertension and isolated systolic hypertension in the Sleep Heart Health Study. Circulation. 2005; 111 ( 5): 614-621.
17. O'Connor GT, Caffo N, Newman AB, et al. Prospective study of sleep-disordered breathing and hypertension: The Sleep Heart Health Study. Am J Respir Crit Care Med. 2009; 179 ( 12): 1159-1164.
18. Kapur VK, Resnick HE, Gottlieb DJ; Sleep Heart Health Study Group. Sleep disordered breathing and hypertension: does self-reported sleepiness modify the association? Sleep. 2008; 31 ( 8): 1127-1132.
19. Barbé F, Durán-Cantolla J, Sánchez-de-la-Torre M, et al; Spanish Sleep And Breathing Network. Eff ect of continuous positive airway pressure on the incidence of hypertension and cardiovascular events in nonsleepy patients with obstructive sleep apnea: A randomized controlled tria. JAMA. 2012; 307 ( 20): 2161-2168.
20. Hedner J, Bengtsson-Boström K, Peker Y, Grote L, Råstam L, Lindblad U. Hypertension prevalence in obstructive sleep apnoea and sex: A population-based case-control study. Eur Respir J. 2006; 27 ( 3): 564-570.
21. Cano-Pumarega I, Durán-Cantolla J, Aizpuru F, et al. Obstructive sleep apnea and systemic hypertension: longitudinal study in the general population: The Vitoria Sleep Cohort. Am J Respir Crit Care Med. 2011; 184 ( 11): 1299-1304.
22. Masa JF, Corral J, Sanchez de Cos J, et al; Collaborating group. Eff ectiveness of three sleep apnea management alternatives. Sleep. 2013; 36 ( 12): 1799-1807.
23. ESH/ESC Task Force for the Management of Arterial Hypertension. 2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension. J Hypertens. 2013; 31 ( 10): 1925-1938.
24. Hoshide S, Kario K, Hoshide Y, et al. Associations between nondipping of nocturnal blood pressure decrease and cardiovascular target organ damage in strictly selected community-dwelling normotensives. Am J Hypertens. 2003; 16 ( 6): 434-438.
25. Boggia J, Li Y, Th ijs L, et al; International Database of Ambulatory blood pressure monitoring in relation to Cardiovascular Outcomes (IDACO) investigators. Prognostic accuracy of day versus night ambulatory blood pressure: A cohort study. Lancet. 2007; 370 ( 9594): 1219-1229.
26. Pankow W, Nabe B, Lies A, et al. Influence of sleep apnea on 24-hour blood pressure. Chest. 1997; 112 ( 5): 1253-1258.
27. Loredo JS, Ancoli-Israel S, Dimsdale JE. Sleep quality and blood pressure dipping in obstructive sleep apnea. Am J Hypertens. 2001; 14 ( 9 pt 1): 887-892.
28. Ancoli-Israel S, Stepnowsky C, Dimsdale J, Marler M, Cohen-Zion M, Johnson S. The eff ect of race and sleep-disordered breathing on nocturnal BP "dipping": Analysis in an older population. Chest. 2002; 122 ( 4): 1148-1155.
29. Hla KM, Young T, Finn L, Peppard PE, Szklo-Coxe M, Stubbs M. Longitudinal association of sleep-disordered breathing and nondipping of nocturnal blood pressure in the Wisconsin Sleep Cohort Study. Sleep. 2008; 31 ( 6): 795-800.
30. Ohkubo T, Hozawa A, Yamaguchi J, et al. Prognostic signifi cance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: The Ohasama study. J Hypertens. 2002; 20 ( 11): 2183-2189.
31. Dolan E, Stanton A, Th ijs L, et al. Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: The Dublin outcome study. Hypertension. 2005; 46 ( 1): 156-161.
32. Hansen TW, Li Y, Boggia J, Th ijs L, Richart T, Staessen JA. Predictive role of the nighttime blood pressure. Hypertension. 2011; 57 ( 1): 3-10.
33. Kario K, Pickering TG, Umeda Y, et al. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: A prospective study. Circulation. 2003; 107 ( 10): 1401-1406.
34. Henskens LH, Kroon AA, van Oostenbrugge RJ, et al. Associations of ambulatory blood pressure levels with white matter hyperintensity volumes in hypertensive patients. J Hypertens. 2009; 27( 7): 1446-1452.
35. Perez-Lloret S, Tobilli JE, Cardinali DP, Malateste JC, Milei J. Nocturnal hypertension defi ned by fi xed cut-off limits is a better predictor of left ventricular hypertrophy than non-dipping. Int J Cardiol. 2008; 127 ( 3): 387-389.
36. Cuspidi C, Giudici V, Negri F, Sala C. Nocturnal nondipping and left ventricular hypertrophy in hypertension: An updated review. Expert Rev Cardiovasc Ther. 2010; 8 ( 6): 781-792.
37. Cuspidi C, Sala C, Valerio C, Negri F, Mancia G. Nocturnal hypertension and organ damage in dippers and nondippers. Am J Hypertens. 2012; 25 ( 8): 869-875.
38. Imadojemu VA, Gleeson K, Gray KS, Sinoway LI, Leuenberger UA. Obstructive apnea during sleep is associated with peripheral vasoconstriction. Am J Respir Crit Care Med. 2002; 165 ( 1): 61-66.
39. Jelic S, Bartels MN, Mateika JH, Ngai P, DeMeersman RE, Basner RC. Arterial stiff ness increases during obstructive sleep apneas. Sleep. 2002; 25 ( 8): 850-855.
40. Calhoun DA, Jones D, Textor S, et al; American Heart Association Professional Education Committee. Resistant hypertension: diagnosis, evaluation, and treatment: A scientifi c statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation. 2008; 117 ( 25): e510-e526.
41. Gonçalves SC, Martinez D, Gus M, et al. Obstructive sleep apnea and resistant hypertension: A case-control study. Chest. 2007; 132 ( 6): 1858-1862.
42. Pedrosa RP, Drager LF, Gonzaga CC, et al. Obstructive sleep apnea: The most common secondary cause of hypertension associated with resistant hypertension. Hypertension. 2011; 58 ( 5): 811-817.
43. Demede M, Pandey A, Zizi F, et al. Resistant hypertension and obstructive sleep apnea in the primary-care setting. Int J Hypertens. 2011; 2011 : 340929.
44. Dudenbostel T, Calhoun DA. Resistant hypertension, obstructive sleep apnoea and aldosterone. J Hum Hypertens. 2012; 26( 5): 281-287.
45. Durán-Cantolla J, Aizpuru F, Martínez-Null C, Barbé-Illa F. Obstructive sleep apnea/hypopnea and systemic hypertension. Sleep Med Rev. 2009; 13 ( 5): 323-331.
46. Bazzano LA, Khan Z, Reynolds K, He J. Eff ect of nocturnal nasal continuous positive airway pressure on blood pressure in obstructive sleep apnea. Hypertension. 2007; 50 ( 2): 417-423.
47. Alajmi M, Mulgrew AT, Fox J, et al. Impact of continuous positive airway pressure therapy on blood pressure in patients with obstructive sleep apnea hypopnea: A meta-analysis of randomized controlled trials. Lung. 2007; 185 ( 2): 67-72.
48. Mo L, He QY. Eff ect of long-term continuous positive airway pressure ventilation on blood pressure in patients with obstructive sleep apnea hypopnea syndrome: A meta-analysis of clinical trials [in Chinese]. Zhonghua Yi Xue Za Zhi. 2007; 87 ( 17): 1177-1180.
49. Haentjens P, Van Meerhaeghe A, Moscariello A, et al. The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome: evidence from a meta-analysis of placebo-controlled randomized trials. Arch Intern Med. 2007; 167 ( 8): 757-764.
50. Montesi SB, Edwards BA, Malhotra A, Bakker JP. The effect of continuous positive airway pressure treatment on blood pressure: A systematic review and meta-analysis of randomized controlled trials. J Clin Sleep Med. 2012; 8 ( 5): 587-596.
51. Fava C, Dorigoni S, Dalle Vedove F, et al. Eff ect of CPAP on blood pressure in patients with OSA/hypopnea a systematic review and meta-analysis. Chest. 2014; 145 ( 4): 762-771.
52. Bakker JP, Edwards BA, Gautam SP, et al. Blood pressure improvement with continuous positive airway pressure is independent of obstructive sleep apnea severity [published correction appears in J Clin Sleep Med. 2014;10(6):711].
53. J Clin Sleep Med. 2014; 10 ( 4): 365-369.
54. Bratton DJ, Stradling JR, Barbé F, Kohler M. Eff ect of CPAP on blood pressure in patients with minimally symptomatic obstructive sleep apnoea: A meta-analysis using individual patient data from four randomised controlled trials. Thorax. 2014; 69 (12): 1128-1135.
55. Ift ikhar IH, Valentine CW, Bittencourt LR, et al. Eff ects of continuous positive airway pressure on blood pressure in patients with resistant hypertension and obstructive sleep apnea: A meta-analysis. J Hypertens. 2014; 32 ( 12): 2341-2350.
56. Turnbull F; Blood Pressure Lowering Treatment Trialists' Collaboration. Eff ects of diff erent blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet. 2003; 362 ( 9395): 1527-1535.
57. Martínez-García MA, Capote F, Campos-Rodríguez F, et al; Spanish Sleep Network. Eff ect of CPAP on blood pressure in patients with obstructive sleep apnea and resistant hypertension: The HIPARCO randomized clinical trial. JAMA. 2013; 310 ( 22): 2407-2415.
58. Mokhlesi B, Finn LA, Hagen EW, Young T, Hla KM, Van Cauter E, Peppard PE. Obstructive sleep apnea during REM sleep and hypertension. Results of the Wisconsin Sleep Cohort. Am J Respir Crit Care Med. 2014; 190 ( 10): 1158-1167.
59. Chirinos JA, Gurubhagavatula I, Teff K, et al. CPAP, weight loss, or both for obstructive sleep apnea. N Engl J Med. 2014; 370 ( 24): 2265-2275.
60. Martínez-García MA, Gómez-Aldaraví R, Soler-Cataluña JJ, Martínez TG, Bernácer-Alpera B, Román-Sánchez P. Positive eff ect of CPAP treatment on the control of diffi cult-to-treat hypertension. Eur Respir J. 2007; 29 ( 5): 951-957.
61. L ogan AG, Tkacova R, Perlikowski SM, et al. Refractory hypertension and sleep apnoea: eff ect of CPAP on blood pressure and barorefl ex. Eur Respir J. 2003; 21 ( 2): 241-247.
62. Lozano L, Tovar JL, Sampol G, et al. Continuous positive airway pressure treatment in sleep apnea patients with resistant hypertension: A randomized, controlled trial. J Hypertens. 2010; 28 ( 10): 2161-2168.
63. Litvin AY, Sukmarova ZN, Elfimova EM, et al. Effects of CPAP on "vascular" risk factors in patients with obstructive sleep apnea and arterial hypertension. Vasc Health Risk Manag. 2013; 9 : 229-235.
64. Pedrosa RP, Draguer LF, de Paula LK, Amaro AC, Bortolotto LA, Lorenzi-Filho G. Eff ects of OSA treatment on BP in patients with resistant hypertension: A randomized trial. Chest. 2013; 144 (5): 1487-1494.
65. Ift ikhar IH, Hays ER, Iverson MA, Magalang UJ, Maas AK. Eff ect of oral appliances on blood pressure in obstructive sleep apnea: A systematic review and meta-analysis. J Clin Sleep Med. 2013; 9 ( 2): 165-174.
66. Zou D, Grote L, Eder DN, Radlinski J, Hedner J. A double-blind crossover study of Doxazosin and Enalapril on peripherical vascular tone and nocturnal blood pressure in sleep apnea patients. Sleep Med. 2010; 11 (3): 325-328.
67. Grote L, Wutkewicz K, Knaack L, Ploch T, Hedner J, Peter J H. Association between blood pressure reduction with antihypertensive treatment and sleep apnea activity. Am J Hypertens. 2000; 13 ( 12): 1280-1287.
68. Kraiczi H, Hedner J, Peker Y, Grote L. Comparison of atenolol, amlodipine, enalapril, hydrochlorothiazide, and losartan for antihypertensive treatment in patients with obstructive sleep apnea. Am J Respir Crit Care Med. 2000; 161 ( 5): 1423-1428.
69. Peter JH, Gassel W, Mayer J, et al. Eff ects of cilazapril on hypertension, sleep, and apnea. Am J Med. 1989; 87 ( 6B): 72S-78S.
70. Weichler U, Herres-Mayer B, Mayer J, Weber K, Hoff mann R, Peter JH. Influence of antihypertensive drug therapy on sleep pattern and sleep apnea activity. Cardiology. 1991; 78 ( 2): 124-130.
71. Heitmann J, Greulich T, Reinke C, et al. Comparison of the effects of nebivolol and valsartan on BP reduction and sleep apnoea activity in patients with essential hypertension and OSA. Curr Med Res Opin. 2010; 26 ( 8): 1925-1932.
72. Cicolin A, Mangiardi L, Mutani R, Bucca C. Angiotensin-converting enzyme inhibitors and obstructive sleep apnea. Mayo Clin Proc. 2006; 81 ( 1): 53-55.
73. Nerbass FB, Pedrosa RP, Genta PR, Drager LF, Lorenzi-Filho G. Calcium channel blockers are independently associated with short sleep duration in hypertensive patients with obstructive sleep apnea. J Hypertens. 2011; 29 ( 6): 1236-1241.
74. Bucca CB, Brussino L, Battisti A, et al. Diuretics in obstructive sleep apnea with diastolic heart failure. Chest. 2007; 132 ( 2): 440-446.
75. Gaddam K, Pimenta E, Thomas SJ, et al. Spironolactone reduces severity of obstructive sleep apnoea in patients with resistant hypertension: A preliminary report. J Hum Hypertens. 2010; 24 ( 8): 532-537.